Goldman Sachs’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.5M | Buy |
1,145,534
+360,830
| +46% | +$10.2M | ﹤0.01% | 1419 |
|
|
2025
Q1 | $23.2M | Buy |
784,704
+21,649
| +3% | +$639K | ﹤0.01% | 1595 |
|
|
2024
Q4 | $22.2M | Sell |
763,055
-111,692
| -13% | -$3.25M | ﹤0.01% | 1704 |
|
|
2024
Q3 | $40.2M | Buy |
874,747
+330,696
| +61% | +$15.2M | 0.01% | 1216 |
|
|
2024
Q2 | $22.2M | Buy |
544,051
+28,771
| +6% | +$1.18M | ﹤0.01% | 1526 |
|
|
2024
Q1 | $13.1M | Buy |
515,280
+161,635
| +46% | +$4.12M | ﹤0.01% | 1851 |
|
|
2023
Q4 | $3.2M | Sell |
353,645
-122,265
| -26% | -$1.11M | ﹤0.01% | 2904 |
|
|
2023
Q3 | $3.04M | Sell |
475,910
-79,925
| -14% | -$510K | ﹤0.01% | 2816 |
|
|
2023
Q2 | $6.16M | Sell |
555,835
-457,640
| -45% | -$5.08M | ﹤0.01% | 2413 |
|
|
2023
Q1 | $15.6M | Sell |
1,013,475
-105,312
| -9% | -$1.62M | ﹤0.01% | 1691 |
|
|
2022
Q4 | $24.8M | Buy |
1,118,787
+499,887
| +81% | +$11.1M | 0.01% | 1448 |
|
|
2022
Q3 | $10.1M | Buy |
618,900
+435,617
| +238% | +$7.11M | ﹤0.01% | 2110 |
|
|
2022
Q2 | $2.66M | Buy |
183,283
+61,391
| +50% | +$892K | ﹤0.01% | 3212 |
|
|
2022
Q1 | $2.25M | Buy |
121,892
+11,659
| +11% | +$215K | ﹤0.01% | 3494 |
|
|
2021
Q4 | $2.62M | Sell |
110,233
-234,246
| -68% | -$5.57M | ﹤0.01% | 3299 |
|
|
2021
Q3 | $8.48M | Buy |
344,479
+150,618
| +78% | +$3.71M | ﹤0.01% | 2396 |
|
|
2021
Q2 | $4.79M | Sell |
193,861
-171,184
| -47% | -$4.23M | ﹤0.01% | 2818 |
|
|
2021
Q1 | $7.96M | Buy |
365,045
+140,901
| +63% | +$3.07M | ﹤0.01% | 2357 |
|
|
2020
Q4 | $5.72M | Buy |
224,144
+123,026
| +122% | +$3.14M | ﹤0.01% | 2403 |
|
|
2020
Q3 | $2.85M | Sell |
101,118
-51,823
| -34% | -$1.46M | ﹤0.01% | 2717 |
|
|
2020
Q2 | $4.32M | Buy |
+152,941
| New | +$4.32M | ﹤0.01% | 2422 |
|